2025-04-01 2026-03-31 2026-03-31 false 05833102 HERTS HEALTH LIMITED 2026-06-24 false iso4217:GBP xbrli:pure 05833102 2025-03-31 05833102 2026-03-31 05833102 2025-04-01 2026-03-31 05833102 2024-03-31 05833102 2025-03-31 05833102 2024-04-01 2025-03-31 05833102 bus:SmallEntities 2025-04-01 2026-03-31 05833102 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 05833102 bus:AbridgedAccounts 2025-04-01 2026-03-31 05833102 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 05833102 core:WithinOneYear 2026-03-31 05833102 core:AfterOneYear 2026-03-31 05833102 core:WithinOneYear 2025-03-31 05833102 core:AfterOneYear 2025-03-31 05833102 core:ShareCapital 2026-03-31 05833102 core:SharePremium 2026-03-31 05833102 core:RevaluationReserve 2026-03-31 05833102 core:OtherReservesSubtotal 2026-03-31 05833102 core:RetainedEarningsAccumulatedLosses 2026-03-31 05833102 core:ShareCapital 2025-03-31 05833102 core:SharePremium 2025-03-31 05833102 core:RevaluationReserve 2025-03-31 05833102 core:OtherReservesSubtotal 2025-03-31 05833102 core:RetainedEarningsAccumulatedLosses 2025-03-31 05833102 core:LandBuildings 2026-03-31 05833102 core:PlantMachinery 2026-03-31 05833102 core:Vehicles 2026-03-31 05833102 core:FurnitureFittings 2026-03-31 05833102 core:OfficeEquipment 2026-03-31 05833102 core:NetGoodwill 2026-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 05833102 core:ListedExchangeTraded 2026-03-31 05833102 core:UnlistedNon-exchangeTraded 2026-03-31 05833102 core:LandBuildings 2025-03-31 05833102 core:PlantMachinery 2025-03-31 05833102 core:Vehicles 2025-03-31 05833102 core:FurnitureFittings 2025-03-31 05833102 core:OfficeEquipment 2025-03-31 05833102 core:NetGoodwill 2025-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 05833102 core:ListedExchangeTraded 2025-03-31 05833102 core:UnlistedNon-exchangeTraded 2025-03-31 05833102 core:LandBuildings 2025-04-01 2026-03-31 05833102 core:PlantMachinery 2025-04-01 2026-03-31 05833102 core:Vehicles 2025-04-01 2026-03-31 05833102 core:FurnitureFittings 2025-04-01 2026-03-31 05833102 core:OfficeEquipment 2025-04-01 2026-03-31 05833102 core:NetGoodwill 2025-04-01 2026-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 05833102 core:ListedExchangeTraded 2025-04-01 2026-03-31 05833102 core:UnlistedNon-exchangeTraded 2025-04-01 2026-03-31 05833102 core:MoreThanFiveYears 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments 2026-03-31 05833102 core:Non-currentFinancialInstruments 2025-03-31 05833102 dpl:CostSales 2025-04-01 2026-03-31 05833102 dpl:DistributionCosts 2025-04-01 2026-03-31 05833102 core:LandBuildings 2025-04-01 2026-03-31 05833102 core:PlantMachinery 2025-04-01 2026-03-31 05833102 core:Vehicles 2025-04-01 2026-03-31 05833102 core:FurnitureFittings 2025-04-01 2026-03-31 05833102 core:OfficeEquipment 2025-04-01 2026-03-31 05833102 dpl:AdministrativeExpenses 2025-04-01 2026-03-31 05833102 core:NetGoodwill 2025-04-01 2026-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 05833102 dpl:GroupUndertakings 2025-04-01 2026-03-31 05833102 dpl:ParticipatingInterests 2025-04-01 2026-03-31 05833102 dpl:GroupUndertakings core:ListedExchangeTraded 2025-04-01 2026-03-31 05833102 core:ListedExchangeTraded 2025-04-01 2026-03-31 05833102 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-04-01 2026-03-31 05833102 core:UnlistedNon-exchangeTraded 2025-04-01 2026-03-31 05833102 dpl:CostSales 2024-04-01 2025-03-31 05833102 dpl:DistributionCosts 2024-04-01 2025-03-31 05833102 core:LandBuildings 2024-04-01 2025-03-31 05833102 core:PlantMachinery 2024-04-01 2025-03-31 05833102 core:Vehicles 2024-04-01 2025-03-31 05833102 core:FurnitureFittings 2024-04-01 2025-03-31 05833102 core:OfficeEquipment 2024-04-01 2025-03-31 05833102 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 05833102 core:NetGoodwill 2024-04-01 2025-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 05833102 dpl:GroupUndertakings 2024-04-01 2025-03-31 05833102 dpl:ParticipatingInterests 2024-04-01 2025-03-31 05833102 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 05833102 core:ListedExchangeTraded 2024-04-01 2025-03-31 05833102 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 05833102 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 05833102 core:NetGoodwill 2026-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 05833102 core:LandBuildings 2026-03-31 05833102 core:PlantMachinery 2026-03-31 05833102 core:Vehicles 2026-03-31 05833102 core:FurnitureFittings 2026-03-31 05833102 core:OfficeEquipment 2026-03-31 05833102 core:AfterOneYear 2026-03-31 05833102 core:WithinOneYear 2026-03-31 05833102 core:ListedExchangeTraded 2026-03-31 05833102 core:UnlistedNon-exchangeTraded 2026-03-31 05833102 core:ShareCapital 2026-03-31 05833102 core:SharePremium 2026-03-31 05833102 core:RevaluationReserve 2026-03-31 05833102 core:OtherReservesSubtotal 2026-03-31 05833102 core:RetainedEarningsAccumulatedLosses 2026-03-31 05833102 core:NetGoodwill 2025-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 05833102 core:LandBuildings 2025-03-31 05833102 core:PlantMachinery 2025-03-31 05833102 core:Vehicles 2025-03-31 05833102 core:FurnitureFittings 2025-03-31 05833102 core:OfficeEquipment 2025-03-31 05833102 core:AfterOneYear 2025-03-31 05833102 core:WithinOneYear 2025-03-31 05833102 core:ListedExchangeTraded 2025-03-31 05833102 core:UnlistedNon-exchangeTraded 2025-03-31 05833102 core:ShareCapital 2025-03-31 05833102 core:SharePremium 2025-03-31 05833102 core:RevaluationReserve 2025-03-31 05833102 core:OtherReservesSubtotal 2025-03-31 05833102 core:RetainedEarningsAccumulatedLosses 2025-03-31 05833102 core:NetGoodwill 2024-03-31 05833102 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 05833102 core:LandBuildings 2024-03-31 05833102 core:PlantMachinery 2024-03-31 05833102 core:Vehicles 2024-03-31 05833102 core:FurnitureFittings 2024-03-31 05833102 core:OfficeEquipment 2024-03-31 05833102 core:AfterOneYear 2024-03-31 05833102 core:WithinOneYear 2024-03-31 05833102 core:ListedExchangeTraded 2024-03-31 05833102 core:UnlistedNon-exchangeTraded 2024-03-31 05833102 core:ShareCapital 2024-03-31 05833102 core:SharePremium 2024-03-31 05833102 core:RevaluationReserve 2024-03-31 05833102 core:OtherReservesSubtotal 2024-03-31 05833102 core:RetainedEarningsAccumulatedLosses 2024-03-31 05833102 core:AfterOneYear 2025-04-01 2026-03-31 05833102 core:WithinOneYear 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:CostValuation 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 05833102 core:Non-currentFinancialInstruments core:CostValuation 2026-03-31 05833102 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-03-31 05833102 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 05833102 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 05833102 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 05833102 bus:Director1 2025-04-01 2026-03-31 05833102 bus:Director2 2025-04-01 2026-03-31 05833102 bus:Director3 2025-04-01 2026-03-31 05833102 bus:Director4 2025-04-01 2026-03-31

HERTS HEALTH LIMITED

Registered Number
05833102
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

HERTS HEALTH LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors | BAGG, William, Dr
| BYRNE, Alexandra Rachel, Dr
| GLEKIN, Sammy, Dr
| TRIVEDI, Rushikesh Yogesh

Registered Address | Ramsay Brown Llp The Brentano Suite
| Solar House, 915 High Road
| North Finchley
| N12 8QJ

Registered Number | 05833102 (England and Wales)

HERTS HEALTH LIMITED
Balance Sheet as at
31 March 2026

| Notes | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 4,120 |  |  |  | 4,847
|  |  |  | 4,120 |  |  |  | 4,847
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 52,715 |  |  |  | 58,888 |  |
Cash at bank and on hand |  | 445,527 |  |  |  | 335,564 |  |
|  | 498,242 |  |  |  | 394,452 |  |
Creditors amounts falling due within one year | 5 | (213,933) |  |  |  | (111,615) |  |
Net current assets (liabilities) |  |  |  | 284,309 |  |  |  | 282,837
Total assets less current liabilities |  |  |  | 288,429 |  |  |  | 287,684
Net assets |  |  |  | 288,429 |  |  |  | 287,684
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 985 |  |  |  | 985
Share premium |  |  |  | 57,452 |  |  |  | 57,452
Profit and loss account |  |  |  | 229,992 |  |  |  | 229,247
Shareholders' funds |  |  |  | 288,429 |  |  |  | 287,684

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 24 June 2026, and are signed on its behalf by:
BYRNE, Alexandra Rachel, Dr Director Registered Company No. 05833102

HERTS HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

| Interest income
--- | ---
| Interest income is recognised using the effective interest rate method.

| Defined contribution pension plan
--- | ---
| The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%) |  | Straight line (years)
| Plant and machinery | - |  | 4
| Fixtures and fittings | 15 |  | -
| Office Equipment | 15 |  | -

| Trade and other debtors
--- | ---
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

| Trade and other creditors
--- | ---
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

| Share capital
--- | ---
| Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

2. | Average number of employees
--- | ---

|  | 2026 |  | 2025
| Average number of employees during the year | 15 |  | 14

3. | Tangible fixed assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 April 25 | 19,217
| At 31 March 26 | 19,217
| Depreciation and impairment
| At 01 April 25 | 14,370
| Charge for year | 727
| At 31 March 26 | 15,097
| Net book value
| At 31 March 26 | 4,120
| At 31 March 25 | 4,847

4. | Debtors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 49,788 |  | 57,420
| Prepayments and accrued income | 2,927 |  | 1,468
| Total | 52,715 |  | 58,888

5. | Creditors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 158,811 |  | 43,020
| Taxation and social security | 236 |  | 3,742
| Other creditors | 486 |  | 486
| Accrued liabilities and deferred income | 54,400 |  | 64,367
| Total | 213,933 |  | 111,615

6. | Directors advances, credits and guarantees
--- | ---
| As at the year-end, the company owed the director £486 (2025: £486).

7. | Share capital
--- | ---
| Alloted, called up and fully paid: 985 (2025 : 985) Ordinary of £1 each